Eli Lilly Gets India Nod to Launch Mounjaro Pen

Rollout will intensify rivalry with Novo Nordisk in obesity drug race

- Jessica Jani

Just months after introducing its weight-loss drug Mounjaro in India, US-based Eli Lilly is set to roll out a more convenient, pen-filled version—escalating its rivalry with Novo Nordisk in the country's nascent but high-potential obesity drug market.

The US-based drugmaker announced on Thursday that it has received market authorization from the Central Drugs Standard Control Organisation (CDSCO) to launch the Mounjaro KwikPen, a multi-dose, single-patient-use prefilled pen designed for once-weekly administration.

Until now, the drug was only available in injectable vials, in two dosage strengths.

The full dosage range will soon be available in India, the company said.